Nagaraja Sree Harsha, Juan Rivas-Santisteban, Roopashree T Satish, G S Kumar
Nagaraja Sree Harsha1,2, Juan Rivas-Santisteban3, Roopashree T Satish4, G S Kumar5
1Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
2Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off Sarjapura Road, Bangalore -560 035, Karnataka, India.
3Department of Biotechnology and Biomedicine, Faculty of Biology, Environmental Sciences.
4Chemistry, University of Alcalá, Madrid-Barcelona Road, Km. 33.6, Edificio De Ciencias Calle 24 28805, Alcalá de Henares, Madrid, Spain.
5Department of Pharmacognosy, Government College of Pharmacy, Bengaluru, India.
Volume - 14,
Issue - 4,
Year - 2021
Viruses are change-prone entities often used as models to study evolutionary mechanisms. SARS-CoV-2 has shown a rapid adaptation to its new host, the human. In addition, it is now widely considered to be the most infectious RNA viral particle in humans, due to both efficiency in transmission mechanisms and exposure. Despite the large number of published articles that shed light on this virus, there is no analysis of the quantitative change in the ultrastructure of SARSCoV-2, although it is a useful tool for understanding the evolutionary pattern. To avoid the emergence of at least three completely different viruses, it should appear that an effective vaccine contains the diversification of the SARS-CoV-2 evolutionary tree. In addition, a greater understanding of the physicochemical characteristics acquired by each of the viral haplotypes is required. In the meantime, the following discussion is offered to update developments in this research topic and to relate them so we can answer questions that, until now, have not been addressed.
Cite this article:
Nagaraja Sree Harsha, Juan Rivas-Santisteban, Roopashree T Satish, G S Kumar. Analysis of the Evolutionary pattern of SARS-CoV-2 and its implications in the spread of the disease. Research Journal of Pharmacy and Technology. 2021; 14(4):2229-2. doi: 10.52711/0974-360X.2021.00396
Nagaraja Sree Harsha, Juan Rivas-Santisteban, Roopashree T Satish, G S Kumar. Analysis of the Evolutionary pattern of SARS-CoV-2 and its implications in the spread of the disease. Research Journal of Pharmacy and Technology. 2021; 14(4):2229-2. doi: 10.52711/0974-360X.2021.00396 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-72
1. Wang Chen, Horby Peter W, Hayden Frederick G, Gao George F. A novel coronavirus outbreak of global health concern. The Lancet. Doi: 10.1016/S0140-6736(20)30185-9.
2. Webpage:https://www.cnbc.com/2020/04/21/coronavirus-cases-are-likely-10-to-20- times-higher-in-us-than-reported-former-fda-chief-gottlieb-says.html. Consulted: May 25th 2020.
3. P. Zhou et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
4. Richman DD, Whitley RJ, Hayden FG. Clinical Virology, 4th ed. Washington: ASM Press; 2016.
5. Van Dorp L, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infection, Genetics and Evolution 2020. Doi: https://doi.org/10.1016/j.meegid.2020.104351
6. Goldsmith CS, Tatti KM, Ksiazek TG, et al. Ultrastructural Characterization of SARS Coronavirus. Emerging Infectious Diseases. Doi:10.3201/eid1002.030913.
7. Phylogenetic network analysis of SARS-CoV-2 genomes Peter Forster, Lucy Forster, Colin Renfrew, Michael Forster. PNAS April 28, 2020 117 (17) 9241-9243; first published April 8, 2020. Doi: https://doi.org/10.1073/pnas.2004999117.
8. A Review of Coronavirus Disease-2019 (COVID-19). Tanu Singhal. Indian J Pediatr. 2020; 87(4): 281–286. Published online 2020 Mar 13. Doi: 10.1007/s12098-020-03263-6.
9. Webpage: https://cobcm.net/blogcobcm/2020/04/14/sars-cov-2-biologia-estructura/. Consulted: May 25th 2020.
10. Chhabra HS, Bagaraia V, Keny S, et al. COVID-19: Current Knowledge and Best Practices for Orthopaedic Surgeons [published online ahead of print, 2020 May 18]. Indian J Orthop. 2020;1-15. Doi:10.1007/s43465-020-00135-1.
11. Phylodynamics of SARS-CoV-2 transmission in Spain Francisco Díez-Fuertes, et al. bioRxiv. Doi: https://doi.org/10.1101/2020.04.20.050039.
12. Webpage: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov- China/documentos/ITCoronavirus.pdf. Consulted: May 25th 2020.
13. Barbezange, Cyril et al. “Seasonal Genetic Drift of Human Influenza A Virus Quasispecies Revealed by Deep Sequencing.” Frontiers in microbiology vol. 9 2596. 31 Oct. 2018, Doi:10.3389/fmicb.2018.02596
14. Webpage:https://www.nationalgeographic.com/science/2020/02/what-happens-to- coronavirus-covid-19-in-warmer-spring-temperatures/. Consulted: 25th May 2020.
15. On the origin and continuing evolution of SARS-CoV-2. Xiaolu Tang et al. National Science Review. Doi: https://doi.org/10.1093/nsr/nwaa036.
16. Cárdenas-Conejo, Yair et al. “An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2).” Journal of medical virology, 10.1002/jmv.25758. 13 Mar. 2020, doi:10.1002/jmv.25758.
17. Mutations in SARS-CoV-2 offer insights into virus evolution. Published: 2020. https://www.ucl.ac.uk/news/2020/may/mutations-sars-cov-2-offer-insights-virus-evolution.
18. R. L. Cann, M. Stoneking, A. C. Wilson, Mitochondrial DNA and human evolution.Nature 325, 31–36 (1987).
19. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology 2020; 5,536–544.
20. Coronavirus phylogeny based on a geometric approach Wen-Xin et al. Mol Phylogenet Evol. 2005 Aug; 36(2): 224–232.2005 May 10. Doi: 10.1016/j.ympev.2005.03.030.